ORDINARY SHARE PURCHASE WARRANT G MEDICAL INNOVATIONS HOLDINGS LTD.G Medical Innovations Holdings Ltd. • February 28th, 2023 • Surgical & medical instruments & apparatus
Company FiledFebruary 28th, 2023 IndustryTHIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ThinkEquity LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [●], 2023 (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(g)(8)(A), prior to at 5:00 p.m. (New York City time) on the date that is five (5) years following the Effective Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), up to [●] ordinary shares, par value $3.15 per share, of the Company (the “Ordinary Shares” and such shares issuable upon exercise of this warrant, the “Warrant Shares”), as subject to adjustment hereunder. Provided, however, if the Holder exercises its over-allotment option in full, the Holder shall be entitled to receive up to an additional [•] Warrant Shares
FORM OF ORDINARY SHARES PURCHASE WARRANT URBAN TEA, INC.Urban Tea, Inc. • March 29th, 2021 • Retail-eating places
Company FiledMarch 29th, 2021 IndustryTHIS ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September [ ], 2021 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September [ ], 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Urban Tea, Inc., a British Virgin Islands company (the “Company”), up to _____ Ordinary Shares (as subject to adjustment hereunder, the “Warrant Shares”). This Warrant is part of units (“Units”), each Unit consisting of one ordinary share, no par value, (the “Ordinary Shares”) and Warrant (the “Warrant”) to purchase up to three Ordinary Shares, issued pursuant to that certain Securities Purchase Agreement (the “Purchase Agreement”) dated as of March [ ], 2021 among the Company and the purchasers signatory thereto, as ame